The application is submitted under Article 10(1) of Directive 2001/83/EC as amended (generic application) in all member states claiming to be generic to the originator product Zanidip 10 and 20 mg film-coated tablets, Recordati Pharmaceuticals Ltd. registered since 22 March 1996 in UK and to the reference product marketed in Denmark Zanidip 10 mg and 20 mg film-coated tablets, MEDA registered since 27 January 1997 (10 mg)/ 2 May 2003 (20 mg). To support the application, the applicant has submitted as report one bioequivalence study in which the 20 mg film-coated tablets are compared with Corifeo 20 mg film-coated tablets, UCB GmbH, from the German market, following a single dose in a replicated design under fasting conditions